March 2019 FDA Recall Drug by American Health Packaging
D-1047-2019 - CGMP Deviation

This Class II drug recall was voluntarily initiated by American Health Packaging on March 6, 2019 for the product Drug. The FDA reported the reason for recall as cgmp deviation. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1047-2019

Reason for Recall
CGMP Deviation: Presence of NDEA (N-Nitrosodimethylamine), a carcinogen impurity, detected in the active ingredient.
Initiated
03-06-2019
Reported
03-27-2019
Quantity
3337 cartons

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
American Health Packaging
Nationwide USA and Puerto Rico
Valsartan Tablets USP 160 mg, 100 Tablets (10 x 10) per Unit Dose Blisters, Rx Only, Packaged and Distributed by: American Health Packaging, Columbus, Ohio 43217 (Individual Dose NDC:60687-139-11, Carton NDC#: 60687-139-01)

Batch or Lot Expiration Information

Lot# Lot 179791, Mar 2020